Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
49
pubmed:dateCreated
2010-12-14
pubmed:abstractText
We previously reported that the activity of mesolimbic dopamine neurons of the ventral tegmental area (VTA) is a key determinant of behavioral susceptibility vs resilience to chronic social defeat stress. However, this was based solely on ex vivo measurements, and the in vivo firing properties of VTA dopamine neurons in susceptible and resilient mice, as well as the effects of antidepressant treatments, remain completely unknown. Here, we show that chronic (10 d) social defeat stress significantly increased the in vivo spontaneous firing rates and bursting events in susceptible mice but not in the resilient subgroup. Both the firing rates and bursting events were significantly negatively correlated with social avoidance behavior, a key behavioral abnormality induced by chronic social defeat stress. Moreover, the increased firing rates, bursting events, and avoidance behavior in susceptible mice were completely reversed by chronic (2 week), but not acute (single dose), treatments with the antidepressant medication fluoxetine (20 mg/kg). Chronic social defeat stress increased hyperpolarization-activated cation current (I(h)) in VTA dopamine neurons, an effect that was also normalized by chronic treatment with fluoxetine. As well, local infusion of I(h) inhibitors ZD7288 (0.1 ?g) or DK-AH 269 (0.6 ?g) into the VTA exerted antidepressant-like behavioral effects. Together, these data suggest that the firing patterns of mesolimbic dopamine neurons in vivo mediate an individual's responses to chronic stress and antidepressant action.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-10607649, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-11102497, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-11850457, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-11931738, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-12093909, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-12597856, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-15450094, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-15967985, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-16429123, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-16469931, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-16566899, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-16772172, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-17379666, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-17400299, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-17596440, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-17956738, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-18197479, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-18308824, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-18772037, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-19455174, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-19846068, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-3958786, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147984-7197394
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1529-2401
pubmed:author
pubmed:issnType
Electronic
pubmed:day
8
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
16453-8
pubmed:dateRevised
2011-9-26
pubmed:meshHeading
pubmed-meshheading:21147984-Action Potentials, pubmed-meshheading:21147984-Analysis of Variance, pubmed-meshheading:21147984-Animals, pubmed-meshheading:21147984-Antidepressive Agents, Second-Generation, pubmed-meshheading:21147984-Benzazepines, pubmed-meshheading:21147984-Brain, pubmed-meshheading:21147984-Cardiotonic Agents, pubmed-meshheading:21147984-Chronic Disease, pubmed-meshheading:21147984-Disease Models, Animal, pubmed-meshheading:21147984-Disease Susceptibility, pubmed-meshheading:21147984-Dopamine, pubmed-meshheading:21147984-Electric Stimulation, pubmed-meshheading:21147984-Fluoxetine, pubmed-meshheading:21147984-Male, pubmed-meshheading:21147984-Mice, pubmed-meshheading:21147984-Mice, Inbred C57BL, pubmed-meshheading:21147984-Neural Pathways, pubmed-meshheading:21147984-Neurons, pubmed-meshheading:21147984-Patch-Clamp Techniques, pubmed-meshheading:21147984-Pyrimidines, pubmed-meshheading:21147984-Reward, pubmed-meshheading:21147984-Stress, Psychological, pubmed-meshheading:21147984-Ventral Tegmental Area
pubmed:year
2010
pubmed:articleTitle
Mesolimbic dopamine neurons in the brain reward circuit mediate susceptibility to social defeat and antidepressant action.
pubmed:affiliation
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9070, USA.
pubmed:publicationType
Journal Article